Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Heart Failure Reports

• Publication date

  2017-06-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11897-017-0342-zPMID 28639234PMCID PMC5558204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease

  2017cited by this paper
• Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.

  2017cited by this paper
• Plasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study

  2017cited by this paper
• HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1.

  2017cited by this paper
• Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.

  2016cited by this paper
• Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction

  2016cited by this paper
• Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction

  2016cited by this paper
• 60 A comparison of HFrEF vs HFpEF’s clinical workload and cost in the first year following hospitalisation and enrollment in a disease management program

  2016cited by this paper
• Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender

  2016cited by this paper
• The utility of biomarker risk prediction score in patients with chronic heart failure

  2016cited by this paper
• Serial galectin-3 and future cardiovascular disease in the general population

  2016cited by this paper
• Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis

  2015cited by this paper
• Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I

  2015cited by this paper
• NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.

  2015cited by this paper
• High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

  2015cited by this paper
• Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?

  2014cited by this paper
• Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

  2014cited by this paper
• Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

  2014cited by this paper
• Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.

  2014cited by this paper
• Natriuretic peptides in cardiovascular diseases: current use and perspectives.

  2014cited by this paper
• Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy.

  2014cited by this paper
• Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction?

  2013cited by this paper
• Long-Term Results of Intensified, N-Terminal-Pro-B-Type Natriuretic Peptide–Guided Versus Symptom-Guided Treatment in Elderly Patients With Heart Failure: Five-Year Follow-Up From TIME-CHF

  2013cited by this paper
• Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.

  2013cited by this paper
• Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre‐clinical (stage B) heart failure in the elderly. Results from ‘PREDICTOR’, a population based‐study in central Italy

  2013cited by this paper
• Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the Dallas Heart Study.

  2013cited by this paper
• Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

  2013cited by this paper
• Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes

  2012cited by this paper
• The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances.

  2012cited by this paper
• Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.

  2012cited by this paper
• Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

  2012cited by this paper
• Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study.

  2012cited by this paper
• Cardiac troponin and heart failure in the era of high-sensitivity assays.

  2012cited by this paper
• ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain.

  2012cited by this paper
• Ongoing myocardial damage in patients with heart failure and preserved ejection fraction.

  2012cited by this paper
• Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.

  2012cited by this paper
• Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

  2011cited by this paper
• Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size

  2011cited by this paper
• Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure.

  2011cited by this paper
• Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.

  2010cited by this paper
• Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

  2010cited by this paper
• Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

  2010cited by this paper
• Analytical validation of a high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

  2010cited by this paper
• The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.

  2010cited by this paper
• Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease.

  2010cited by this paper
• Cardiac Myosin Light Chain Kinase Is Necessary for Myosin Regulatory Light Chain Phosphorylation and Cardiac Performance in Vivo*

  2010cited by this paper
• The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.

  2009cited by this paper
• Early diagnosis of myocardial infarction with sensitive cardiac troponin assays.

  2009cited by this paper
• The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

  2008cited by this paper
• Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.

  2008cited by this paper
• IL-33 reduces the development of atherosclerosis

  2008cited by this paper
• Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).

  2008cited by this paper
• Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.

  2007cited by this paper
• Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

  2007cited by this paper
• Investigation of Major Genetic Polymorphisms in the Renin-Angiotensin-Aldosterone System in Subjects with Young-Onset Hypertension Selected by a Targeted-Screening System at University

  2007cited by this paper
• Prevalence and Determinants of Troponin T Elevation in the General Population

  2006cited by this paper
• Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.

  2006cited by this paper
• Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

  2006cited by this paper
• Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes

  2006cited by this paper
• Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats.

  2006cited by this paper
• Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.

  2006cited by this paper
• N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

  2005cited by this paper
• N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults

  2005cited by this paper
• Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure

  2005cited by this paper
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

  2004cited by this paper
• Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study.

  2004cited by this paper
• Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction

  2004cited by this paper
• Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions

  2004cited by this paper
• Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.

  2004cited by this paper
• A novel biochemical approach to congestive heart failure: cardiac troponin T.

  1999cited by this paper
• Myosin light chain phosphatase: subunit composition, interactions and regulation

  1998cited by this paper

• Association of cardiac biomarkers with longitudinal cognitive changes in the general population

  2026cites this paper
• Artificial Intelligence for Exosomal Biomarker Discovery for Cardiovascular Diseases: Multi-Omics Integration, Reproducibility, and Translational Prospects

  2026cites this paper
• Subclinical Cardiac Dysfunction and Circulating Markers of Brain Injury in Older Adults: the Cardiovascular Health Study.

  2025cites this paper
• Integrative bioinformatic analysis of prognostic biomarkers in heart failure: Insights from clinical trials

  2025cites this paper
• Cardiac Biomarkers and Malnutrition Incidence in Community-Dwelling Older Adults without Cardiovascular Disease: The Seniors-ENRICA-2 Cohort.

  2025cites this paper
• Inter-technique agreement of left atrial and ventricular deformation analysis: a comparison between transthoracic echocardiography and cardiovascular magnetic resonance imaging

  2025cites this paper
• Evaluating the Prognostic Significance of Circulating Biomarkers of End Organ Damage in Hypertension

  2025cites this paper
• Ultra-Processed Food Consumption and Subclinical Cardiac Biomarkers: A Cross-Sectional Analysis of U.S. Adults in NHANES 2001–2004

  2025cites this paper
• Effects of vitamin D supplementation on cardiac biomarkers: Results from the STURDY trial

  2024cites this paper
• Plasma B-type natriuretic peptide is independently associated with cardiovascular events and mortality in patients with chronic kidney disease

  2024cites this paper
• Predictive value of NT pro BNP for new‐onset atrial fibrillation in heart failure and preserved ejection fraction

  2024cites this paper
• Epichaperome-targeted myocardial imaging by 124I-PU-H71 PET

  2024cites this paper
• Serum Copeptin in Cardiooncology Practice: Review of Pathophysiological and Clinical Implications

  2023cites this paper
• Optimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

  2023cites this paper
• Methods for Assessing Health Outcomes Associated with Food Insecurity in the United States College Student Population: A Narrative Review

  2023cites this paper
• Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC).

  2022cites this paper
• Association of longitudinal changes in NT-proBNP with changes in Left Atrial Volume and Function: MESA.

  2021cites this paper
• Determining Which Hospitalized Coronavirus Disease 2019 Patients Require Urgent Echocardiography

  2021cites this paper
• Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction—Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage

  2021influential citation
• Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era

  2021cites this paper
• Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of ischemic origin

  2021cites this paper
• The Association of Diurnal Blood Glucose Variability With Subclinical Cardiac Disease in Patients With Type 2 Diabetes Mellitus

  2020cites this paper
• CARDIOVASCULAR DISEASE RISK ASSESSMENT WITH HIGH-SENSITIVITY CARDIAC TROPONIN I AND OTHER BIOMARKERS: AN OBSERVATIONAL COHORT STUDY IN JOHOR, MALAYSIA

  2020influential citation
• Plasma-derived exosomal miR-183 associates with protein kinase activity and may serve as a novel predictive biomarker of myocardial ischemic injury

  2019cites this paper
• Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis

  2018cites this paper
• Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure

  2018cites this paper
• In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers

  2018cites this paper
• Using Peptidomics to Identify Extracellular Matrix-Derived Peptides as Novel Therapeutics for Cardiac Disease

  2018cites this paper
• Untreated Obstructive Sleep Apnea Is Associated With Myocardial Injury Independent of Blood Pressure Control in Hypertension

  2018cites this paper
• ОЦІНКА ВІДДАЛЕНИХ НЕСПРИЯТЛИВИХ СЕРЦЕВО-СУДИННИХ ПОДІЙ У

  year unknowncites this paper